ITM Isotope Technologies Munich SE shared a post on LinkedIn:
“ITM is heading to ASCO GI in San Francisco, California!
The American Society of Clinical Oncology (ASCO) GI Conference kicks off this week, and ITM is starting the year engaging with experts in gastrointestinal cancer to discuss the latest innovations, solution-focused strategies, and multidisciplinary approaches shaping GI cancer treatment, research, and care.
Visit ITM at Booth #35 in the exhibit hall
🗓 January 8–9 | 7:00 AM – 7:00 PM
Stop by to explore the potential of Targeted Radiopharmaceutical Therapy (RPT) in addressing a range of high-need cancer indications and learn more about ITM’s role in advancing this innovative modality.
As the global burden of cancer continues to rise, discussions around emerging evidence and next-generation approaches like RPT are more important than ever.
Learn more about ITM’s robust RPT pipeline.
Let’s shape the future of the ranostics together—see you in San Francisco!”
More about ASCO GI.